Group 1 - The beauty and personal care sector has shown a recovery in 2025, with the SW Beauty Index rebounding after a decline from 2022 to 2024, achieving a maximum increase of over 15% and becoming a key area in new consumption [3][9][10] - The cosmetics segment is characterized by intense competition among brands, with domestic brands making significant strides in R&D and distribution, while international brands are adopting localized strategies to regain market share [3][20][25] - The medical beauty market is transitioning from a blue ocean to a red ocean, with domestic companies expected to become major competitors by focusing on affordable and specialized products [3][19][24] Group 2 - The e-commerce operation sector is undergoing a transformation, with companies like RuYuchen and Shuiyang Co. leveraging brand incubation and AI to create new growth avenues [3][19] - Key investment recommendations include domestic brands with strong channel and brand matrices such as MaoGePing, ShangMei Co., and PoLaiYa, as well as companies in the medical beauty sector like AiMeiKe and LongZi Co. [3][19][24] - The report emphasizes the importance of brand matrix construction and product innovation in the cosmetics industry, with companies like ShangMei Co. and PoLaiYa leading the way [3][31][40] Group 3 - The skincare and makeup market is expected to enter a phase of consolidation, with strong brands likely to thrive while weaker ones may struggle [23][24] - The market share of domestic brands is increasing, with a notable decline in the market share of international brands, indicating a significant opportunity for domestic players [25][30] - The report highlights the importance of adapting to changing consumer preferences and channel dynamics, with a focus on online platforms and promotional strategies to enhance brand visibility [48][52][53]

Core Viewpoint - The cosmetics industry is undergoing a strategic transformation from basic moisturizing to efficacy-driven and scientific approaches, with peptides emerging as key active ingredients in anti-aging skincare products [3][4]. Market Size and Growth Trends - The global peptide cosmetics market is rapidly growing, with projections indicating a market size of $2.566 billion in 2024, expected to reach $5.716 billion by 2031, reflecting a compound annual growth rate (CAGR) of 12.3% during the forecast period [6][8]. - In 2024, over 55 million consumers are expected to use peptide skincare products, with 68% targeting wrinkle reduction and skin tightening [9]. Regional Market Performance - The Asia-Pacific region is the largest market for peptide cosmetics, accounting for 36% of global sales, with South Korea alone selling over 12.7 million units in 2023 [10][11]. - North America follows closely, representing 34% of global sales, with the U.S. having over 16.2 million active peptide skincare users [12][13]. - Europe contributes 28% of global sales, with Germany, the UK, and France leading the market [11][12]. Segment Market Performance - Serums are the largest segment, accounting for 38% of global sales, with over 480 peptide serums launched in 2023 [15]. - Moisturizing repair creams hold a 26% market share, while anti-aging creams account for 17% [15]. - Eye creams represent 11% of the segment, with 95 peptide SKUs recorded in 2023 [15]. Sales Channel Performance - Online sales dominate the market, accounting for 46% of total sales, with over 37 million peptide products sold through e-commerce platforms in 2023 [16]. - Specialty cosmetics stores contribute 27% to global sales, while supermarkets account for 18% [16]. Capital Flow and Investment Trends - In 2023, the global peptide cosmetics market attracted over $1.12 billion in funding, primarily directed towards R&D, clinical trials, and sustainable packaging [18][19]. - North America received over $360 million in investments, focusing on biotechnology-based peptide platforms [18]. Product Innovation - Over 110 new peptide products were launched globally between 2023 and 2024, showcasing a trend towards multi-peptide formulations and precision delivery systems [20]. - Brands are increasingly integrating AI for personalized skincare solutions, with over 145 brands utilizing AI skin diagnostic systems [20]. Competitive Landscape - The competitive landscape is shifting, with L'Oréal leading the market, followed by Estée Lauder and emerging brands like Han Shu [21][22]. - Han Shu's Red Waist 2.0 series achieved remarkable sales, emphasizing innovative raw material development and effective marketing strategies [22][25]. Raw Material Market Expansion - The peptide manufacturing market is projected to reach $2.574 billion by 2025, with a CAGR of 5.4% from 2025 to 2035 [26]. - There is a growing trend towards sustainable sourcing of peptides, with plant-based peptides gaining traction [26]. Challenges and Development - High costs and stability issues remain significant challenges, with 41% of brands reporting delays in product launches due to packaging and preservation difficulties [27]. - Regulatory fragmentation is also a concern, with only 27 countries having established guidelines for peptide ingredients [27]. Conclusion - The global peptide cosmetics market is in a phase of high growth and innovation, driven by technological advancements and evolving consumer demands, with a competitive landscape characterized by both established leaders and emerging players [29][31].

Investment Rating - The report upgrades the investment rating to "Buy" for the company [5] Core Views - The company is transitioning towards a multi-brand beauty group, with a focus on operational efficiency and data-driven strategies to enhance growth certainty [14][15] - The main brand, Han Shu, has shown significant revenue growth through effective channel strategies, particularly on Douyin, and is expected to continue this trend [5][15] - The company has successfully launched new brands and product lines, contributing to its revenue and market presence [5][14] Summary by Sections 1. Transition to a Multi-Brand Beauty Group - The company is evolving into a multi-brand beauty group, with Han Shu as its main brand, achieving revenue of 41.1 billion RMB in 25H1, a year-on-year increase of 17.3% [14] - The net profit for the same period was 5.6 billion RMB, reflecting a year-on-year growth of 34.7% [14] 2. Channel Strategy - The company has leveraged its historical experience to capitalize on sales and marketing opportunities, particularly through Douyin, which has become a key growth driver [24][31] - The transition from B2B to B2C has led to a significant increase in online self-operated channels, with Douyin's contribution to revenue rising sharply [19][22] 3. Product Development - The company has focused on developing high-quality products with competitive pricing, exemplified by the success of the "Red Waist" series, which has become a best-seller [52][54] - The introduction of the "X Peptide" series has also shown promising sales, with total sales exceeding 200 million RMB [61] 4. Operational Efficiency - The company's operational strategies have shifted towards a platform model, emphasizing top-tier resources and talent to enhance brand development [5][14] - The focus on data-driven decision-making has improved the company's ability to respond to market trends and consumer preferences [31][32]

Core Viewpoint - The company, Up Beauty Co., has demonstrated strong financial performance in the first half of the year, with significant year-on-year growth in both revenue and net profit, reflecting its robust market position and operational efficiency [1][7]. Financial Performance - Up Beauty Co. achieved a revenue of 4.108 billion yuan, representing a year-on-year increase of 17.3%, and a net profit of 556 million yuan, up 34.7% year-on-year, indicating a strong growth trajectory [1]. - The gross profit reached 3.12 billion yuan, with a gross margin of 75.5%, which is an increase of 1.7 percentage points from the previous period, showcasing high profitability [1]. - The earnings per share were 1.32 yuan, a 30.7% increase year-on-year, with a mid-term dividend of 0.5 yuan per share, reflecting solid cash flow and a commitment to shareholder returns [7]. Market Position and Growth Strategy - The new consumption sector in the Hong Kong stock market has become a focal point for capital, with Up Beauty Co. positioned as a leading player benefiting from the rising trend of self-care consumption and emotional value in spending [1][2]. - The company employs a multi-brand strategy that enhances market coverage and product competitiveness, with its main brand, Han Shu, achieving a revenue of 3.344 billion yuan, a 14.3% increase year-on-year [8][9]. - The brand newpage has also shown remarkable growth, with a revenue of 397 million yuan, marking a 146.5% increase year-on-year, indicating strong market penetration [9]. Research and Development - Up Beauty Co. invested over 103 million yuan in R&D, a 31.7% increase year-on-year, which constitutes 2.5% of its revenue, and holds nearly 200 patents, enhancing its innovation capabilities [13]. - The establishment of the Han Shu Translational Medicine Fund aims to strengthen the integration of research and practical application, further supporting product innovation [13]. Future Growth Potential - The company is well-positioned to benefit from the ongoing transformation in the cosmetics industry, with domestic brands capturing 55% of the market share, indicating a shift towards local products [14][15]. - Up Beauty Co. plans to launch new brands, including high-end anti-aging and makeup lines, leveraging strong partnerships and its existing R&D capabilities to meet diverse consumer needs [18][21]. - The company is also expanding its global footprint, particularly in Southeast Asia, which presents new growth opportunities [22].

Core Viewpoint - The article highlights the strong performance and growth potential of the beauty company, Shiseido Holdings (上美股份), driven by a multi-brand strategy, innovative product development, and a comprehensive sales channel approach, amidst a rising trend of young consumers prioritizing experience and value in their purchasing decisions [1][2][11]. Financial Performance - In the first half of 2025, Shiseido Holdings reported total revenue of approximately 4.108 billion RMB, a year-on-year increase of 17.3% [2] - The net profit reached about 555.6 million RMB, reflecting a 34.7% increase compared to the previous year [2] - Gross profit was approximately 3.102 billion RMB, with a year-on-year growth of 15.8%, resulting in a gross margin of 75.5%, up 1.7 percentage points from the previous period [2] - Basic earnings per share for the first half of 2025 were 1.32 RMB, a 30.7% increase year-on-year [2] Multi-Brand Strategy - The company's strong performance is attributed to its deepening multi-brand strategy, with its main brand, Han Shu (韩束), achieving revenue of approximately 3.344 billion RMB, a 14.3% increase year-on-year [3] - Han Shu's star product, the Red Waist series, sold over 15 million units, establishing itself as a national skincare staple [3] - The new brand, Newpage (一页), showed remarkable growth with revenue of 397 million RMB, a 146.5% increase year-on-year, indicating its successful entry into the baby care market [5] Sales Channel Development - Shiseido Holdings has effectively implemented a comprehensive sales channel strategy, with Han Shu ranking first in monthly GMV on Douyin in the first half of 2025 [10] - The brand has also seen significant growth across various e-commerce platforms, including Tmall, Vipshop, Pinduoduo, and Kuaishou, creating a robust sales ecosystem [10] Research and Development - The company invested over 103 million RMB in R&D in the first half of 2025, a 31.7% increase year-on-year, resulting in nearly 200 patents and several publications in global core journals [11] - The establishment of the "Han Shu Translational Medicine Fund" signifies the company's commitment to integrating academic and medical resources to enhance product innovation [12] International Expansion - Shiseido Holdings is actively pursuing international growth, particularly in Southeast Asia, aiming to elevate its brand from a "Chinese brand" to a "global brand" [13] - The company's international strategy is expected to open new growth avenues and enhance its global market presence [13]

Core Viewpoint - The article highlights the strong performance and growth potential of the beauty company, Shiseido Holdings (上美股份), driven by a multi-brand strategy, innovative product development, and a comprehensive sales channel approach, amidst a rising trend of young consumers prioritizing experience and value in their purchasing decisions [1][2][12]. Financial Performance - In the first half of 2025, Shiseido Holdings reported total revenue of approximately 4.108 billion RMB, a year-on-year increase of 17.3% [2] - The net profit reached about 555.6 million RMB, up 34.7% compared to the previous year, with a gross profit of approximately 3.102 billion RMB, reflecting a 15.8% increase [2] - The gross margin improved to 75.5%, marking a 1.7 percentage point increase from the previous period, indicating high-quality core business development [2] Multi-Brand Strategy - The company's strong performance is attributed to its deepening multi-brand strategy, with its main brand, Han Shu (韩束), achieving revenue of approximately 3.344 billion RMB, a 14.3% increase year-on-year [3] - Han Shu's star product, the Red Waist series, sold over 15 million units, establishing itself as a national skincare staple, while the X Peptide Super Frequency series surpassed 200 million RMB in sales [3][5] - The brand has successfully expanded into various product categories, achieving top sales in body lotion, shampoo, masks, and facial cleansers, transitioning from a facial skincare brand to a comprehensive care expert [3][5] Emerging Brands - The emerging brand, Newpage (一页), demonstrated significant growth, with revenue of 397 million RMB, a remarkable 146.5% increase year-on-year, and online sales exceeding the total for 2024 [5][6] - Newpage's flagship product, the Baby Comfort Cream, sold 330,000 units during the 618 shopping festival, ranking first in the Tmall and Douyin categories for baby creams [6] Sales Channels - The company has established a robust omnichannel sales strategy, with Han Shu ranking first in GMV on Douyin in the first half of 2025, contributing to significant growth across various e-commerce platforms [11] - This comprehensive sales ecosystem reflects the company's deep understanding of consumer behavior and market trends, enhancing brand loyalty and driving high potential across its product lines [11] Research and Development - Shiseido Holdings invested over 103 million RMB in R&D in the first half of 2025, a 31.7% increase year-on-year, resulting in nearly 200 patents and publications in global core journals [12][13] - The establishment of the "Han Shu Translational Medicine Fund" signifies the company's commitment to integrating academic and medical resources to accelerate product innovation [13] International Expansion - The company is actively pursuing international growth, particularly in Southeast Asia, aiming to enhance its global brand presence and transition from a "Chinese brand" to a "global brand" [14] - This strategic move is expected to open new growth avenues and increase the company's international influence [14] Conclusion - The impressive performance of Shiseido Holdings in the first half of 2025 is a result of its deepened multi-brand strategy, enhanced product capabilities, and optimized channel efficiency, positioning it as a key player in the domestic beauty market [14]

Investment Rating - The report gives a "Buy" rating for the company, marking its first coverage [1]. Core Insights - The company is expected to achieve stable growth over the next three years through its "2+2+2" strategy, which focuses on skincare, hair care, and maternal and infant care, supported by a rich reserve of new brands [3][4]. - The main brand, Han Shu, maintains a leading position in the anti-aging skincare sector, with significant expansion into men's and color cosmetics, while new brands like NEWPAGE are rapidly gaining traction in the infant skincare market [10][11]. - The company's revenue is projected to grow significantly, with total revenue expected to reach 67.9 billion yuan in 2024, a year-on-year increase of 61.2%, and net profit expected to reach 7.8 billion yuan, up 69.4% [10][11]. Summary by Sections 1. Company Overview - The company is a leading multi-brand cosmetics enterprise in China, focusing on skincare, maternal and infant care, and hair care products. It has successfully built a brand matrix that includes popular brands like Han Shu and NEWPAGE [17]. - The company has experienced strong revenue growth, with a compound annual growth rate (CAGR) of 19.0% from 2020 to 2024, driven by the explosive growth of its main brand Han Shu [31]. 2. Brand Strategy - The "2+2+2" strategy integrates two major brands in skincare, two in maternal and infant care, and two in hair care, creating a diversified brand matrix that meets various consumer needs [42]. - Han Shu accounts for approximately 82.3% of total revenue, with a strong performance in the anti-aging market, while NEWPAGE has emerged as a significant growth driver in the infant skincare segment [46][60]. 3. Financial Performance - The company’s revenue is projected to grow from 42.1 billion yuan in 2023 to 67.9 billion yuan in 2024, with net profit expected to increase from 1.3 billion yuan to 7.8 billion yuan during the same period [31][11]. - The gross margin has improved significantly, rising from 60.9% in 2019 to 75.2% in 2024, reflecting the success of the high-end product strategy [33]. 4. Sales Channels - Online sales have become a major revenue source, with the online channel accounting for 90.5% of total revenue in 2024, driven by the strong performance of Han Shu and the rapid growth of NEWPAGE [37]. - The company has increased its self-operated sales proportion from 46.7% in 2020 to 78.2% in 2024, indicating a shift towards more direct sales strategies [37]. 5. Future Growth Drivers - The company is expanding its brand matrix with new brands targeting specific market segments, such as the high-end infant skincare market with NEWPAGE and the maternal care market with Red Elephant [60][68]. - The focus on innovation and research is expected to drive future growth, particularly in the clean beauty segment with brands like One Leaf [68].

Core Viewpoint - Shanghai Shangmei Cosmetics Co., Ltd. (02145.HK) has released a positive profit forecast for the first half of 2025, indicating strong revenue and net profit growth driven by its main brand Han Shu and the second growth curve brand New Page [1][2] Group 1: Financial Performance - For the first half of 2025, the company expects revenue to be between RMB 4.09 billion and RMB 4.11 billion, representing a year-on-year growth of 16.8% to 17.3% [1] - The net profit is projected to reach between RMB 540 million and RMB 560 million, showing a significant year-on-year increase of 30.9% to 35.8% [1] Group 2: Brand Strategy - The company is advancing a "single focus, multi-brand, globalization" strategy, creating a multi-brand matrix that includes the main brand Han Shu and the second curve brand New Page, achieving comprehensive layout across multiple categories and price ranges [2][10] - Han Shu has achieved a breakthrough in all-channel growth, with GMV on Douyin exceeding RMB 3.63 billion in the first half of 2025, maintaining its position as the top-selling beauty brand on the platform [4] Group 3: Product Innovation - The Han Shu brand has successfully launched innovative products, such as the Hong Man Yao series, which sold over 14 million sets, and the Bai Man Yao series targeting the whitening market, reinforcing the brand's market recognition for "functional skincare" [4] - New Page has shown strong growth since its launch in 2022, with a strategic upgrade focusing on "effective skincare" for all age groups, achieving a sales increase of 106% during the 618 shopping festival [6] Group 4: Competitive Advantage - The Anminyou brand targets the sensitive skin segment with its core ingredient "Artemisia Oil AN+", providing a gentle solution for sensitive skin, enhancing the company's professional skincare portfolio [8] - The company has established a complete innovation matrix in the hair care sector, launching differentiated brands like Jifang and Han Shu Hair Care, focusing on functional hair care and scalp anti-aging [8] Group 5: Research and Development - The company emphasizes R&D as a strategic priority, having established a 3.0 innovation R&D system and an "1+N open innovation platform" to integrate global scientific resources [11] - In 2024, Han Shu achieved a significant technological breakthrough with the approval of its self-developed cyclic peptide-9 anti-aging ingredient by the National Medical Products Administration [13] Group 6: Manufacturing and Future Goals - The company has built an international and intelligent production system, with a smart factory that operates fully automated processes from raw material scheduling to finished product delivery [14] - The company aims to reach a strategic target of RMB 30 billion by 2030, leveraging clear strategic planning and continuous R&D investment to transition from following international brands to leading industry development [16]

Summary of Shangmei Co., Ltd. Conference Call Company Overview - Shangmei Co., Ltd. reported a revenue of 6.7 billion RMB in 2024, representing a year-on-year growth of 62.1%, with net profit increasing by 74% [2][3] - The company was founded in 2002 and focuses on skincare, hair care, and maternal and infant products, with brands including Han Shu, New Page, Yi Ye Zi, Red Elephant, and Anminyou [3] Core Strategies and Insights - **Brand Premiumization Strategy**: Shangmei adopts a dual-track strategy for brand premiumization, enhancing product efficacy through self-developed core ingredients (e.g., Anminyou's artemisinin oil) and IP collaborations (e.g., with the "Anpanman" brand for maternal and infant care) [2][4] - **Channel Strategy Adjustment**: The company is shifting from a heavy focus on Douyin to a multi-channel approach, with Douyin's channel share slightly decreasing to 75% in Q1 2025, while Tmall and JD.com are gaining share [2][6] - **"2+2+2" Brand Strategy**: This strategy targets mass, mid-to-high-end, and high-end markets across skincare, maternal and infant care, and hair care categories [2][7] Product Performance - **Han Shu Brand**: Han Shu's red waist series 2.0 version has sold over 14 million sets, and new high-margin products like Chatai Super Frequency Cream are expected to enhance profitability [2][8] - **Growth Projections**: The Han Shu brand is expected to achieve approximately 20% growth in 2025, driven by anti-aging, men's skincare, and color cosmetics segments [2][9] Future Growth Drivers - **Emerging Brands**: New Page is rapidly growing in the maternal and infant care market, with plans to expand into teenage care and color cosmetics [2][9] - **New Product Launches**: The upcoming brands, such as Nambeauty and the Anpanman collaboration, are projected to achieve over 100 million RMB in sales in their first year [2][9] Profitability Enhancement Measures - **High-Margin Product Focus**: Increasing the proportion of high-margin new products, such as Han Shu's new offerings, is expected to boost overall gross and net profit margins [2][10] - **Channel Optimization**: A strategic reduction in the proportion of live streaming sales and an increase in self-broadcasting and high-margin channels like Tmall and JD.com will enhance profitability [2][10] - **Sales Expense Reduction**: The company anticipates a gradual decrease in sales expense ratio, projected to drop by about 1 percentage point annually from 2025 to 2027 [2][10] Financial Outlook - Shangmei is expected to achieve revenue growth rates of 24.1%, 20.8%, and 20.7% from 2025 to 2027, with adjusted net profits growing by 33.8%, 21.4%, and 18.8% respectively [2][10]

Investment Rating - The report initiates coverage with a "Buy" rating for the company [4][6]. Core Insights - The company has established itself as a leading domestic beauty group through a multi-brand strategy, with a strong focus on product innovation and market responsiveness [2][18]. - The company is expected to achieve steady revenue growth driven by its main brand, Han Shu, and the gradual ramp-up of its sub-brands [4][31]. Summary by Sections Company Overview - The company has been deeply engaged in the beauty industry for over 20 years, launching multiple brands including Han Shu, Yi Ye Zi, and Hong Se Xiao Xiang, and is preparing to introduce new high-end and baby care brands [1][18]. Financial Analysis - The company experienced a significant revenue increase in 2023, with projected revenues of 67.93 billion and a net profit of 7.81 billion in 2024, reflecting growth rates of 62.08% and 69.42% respectively [5][25]. Business Operations - The company operates a diverse product matrix, with Han Shu accounting for 82% of revenue in 2024, while sub-brands are gradually gaining traction [30][31]. - The company is expanding its channel presence, particularly in Tmall, to complement its strong performance on Douyin [44][47]. Core Advantages - The company has established a robust R&D and marketing framework, with significant investments in proprietary research and a strong marketing presence on platforms like Douyin [3][22]. - The company’s main brand, Han Shu, has positioned itself effectively in the market, leveraging high-quality, cost-effective products to capture consumer interest [35][42]. Profitability Forecast - The company forecasts revenues of 84.90 billion, 102.89 billion, and 123.07 billion for 2025, 2026, and 2027 respectively, with corresponding net profits of 10.04 billion, 12.50 billion, and 15.20 billion [4][5].